Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH logo National Institutes of Health
  1. Home
  2. Research
  3. Pre-Clinical Innovation

Pre-Clinical Innovation

A family of proteins, including the cancer target protein NSD2, surround a cell’s nucleosome.
New Approach to Identify Potential Cancer Drugs

NCATS researchers develop a series of assays (tests) to identify compounds that disrupt a driver of several cancers.

NCATS Robots
Accelerating Drug Discovery

Using NCATS’ ASPIRE program in pre-clinical drug discovery, scientists can study unexplored biologically active chemical space through integrating automated synthetic chemistry, high-throughput biology and artificial intelligence technologies.

Improving the Drug Development Process

Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster.

Repurposing Drugs

Discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside.

Testing & Predictive Models

Developing better model systems for drug and toxicity testing.

Core Technologies

Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.

Improving the Drug Development Process

Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster.

Repurposing Drugs

Discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside.

Testing & Predictive Models

Developing better model systems for drug and toxicity testing.

Core Technologies

Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.